SLGL

Sol-Gel Technologies (SLGL)

About Sol-Gel Technologies (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high
$71.00
Daily low
$68.00
Price at open
$68.00
52 Week High
$97.97
52 Week Low
$6.80
Market cap
231.6M
Dividend yield
0.00%
Volume
11,288
Avg. volume
34,975
P/E ratio
-32.22

Sol-Gel Technologies News

Details

Daily high
$71.00
Daily low
$68.00
Price at open
$68.00
52 Week High
$97.97
52 Week Low
$6.80
Market cap
231.6M
Dividend yield
0.00%
Volume
11,288
Avg. volume
34,975
P/E ratio
-32.22